Therapeutic Drug Monitoring of Aminoglycosides in Neonates

被引：0
|
作者：
Matthijs de Hoog
John N. van den Anker
机构：
[1] Sophia Children’s Hospital,Intensive Care Unit, Department of Pediatrics, Erasmus Medical Center
[2] Children’s National Medical Center/George Washington University School of Medicine and Health Sciences,Departments of Pediatrics, Pharmacology and Physiology
来源：
Clinical Pharmacokinetics | 2009年 / 48卷
关键词：
Hearing Loss; Aminoglycosides; Predictive Performance; Therapeutic Drug Monitoring; Pharmacokinetic Behaviour;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：343 / 344
页数：1
相关论文
共 50 条
  • [21] Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates
    Dua’a Alrahahleh
    Yann Thoma
    Ruth Van Daele
    Thi Nguyen
    Stephanie Halena
    Melissa Luig
    Sophie Stocker
    Hannah Yejin Kim
    Jan-Willem Alffenaar
    Clinical Pharmacokinetics, 2024, 63 : 367 - 380
  • [22] Therapeutic Drug Monitoring in Neonates: What Makes them Unique?
    Mian, P.
    Flint, R. B.
    Tibboel, D.
    van den Anker, J. N.
    Allegaert, K.
    Koch, B. C. P.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (38) : 5790 - 5800
  • [23] Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates
    Alrahahleh, Dua'a
    Thoma, Yann
    Van Daele, Ruth
    Nguyen, Thi
    Halena, Stephanie
    Luig, Melissa
    Stocker, Sophie
    Kim, Hannah Yejin
    Alffenaar, Jan-Willem
    CLINICAL PHARMACOKINETICS, 2024, 63 (03) : 367 - 380
  • [24] Therapeutic drug monitoring (TDM) of gentamicin in critically ill neonates
    Martinkova, J.
    Pokorna, P.
    Zahora, J.
    Selke-Krulichova, I.
    PROCEEDINGS OF THE 8TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, : 163 - +
  • [25] Therapeutic Drug Monitoring of Antimicrobial Drugs in Neonates: An Opinion Article
    Touw, Daan J.
    van den Anker, John N.
    THERAPEUTIC DRUG MONITORING, 2022, 44 (01) : 65 - 74
  • [26] A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants
    Hutchinson, Laura
    Sinclair, Marlene
    Reid, Bernadette
    Burnett, Kathryn
    Callan, Bridgeen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (06) : 1089 - 1108
  • [27] Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates
    Yu, Tian
    Balch, Alfred H.
    Ward, Robert M.
    Korgenski, E. Kent
    Sherwin, Catherine M. T.
    BMC PHARMACOLOGY & TOXICOLOGY, 2016, 17
  • [28] Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring
    Zhao, Wei
    Lopez, Emmanuel
    Biran, Valerie
    Durrmeyer, Xavier
    Fakhoury, May
    Jacqz-Aigrain, Evelyne
    ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (06) : 449 - 453
  • [29] FUROSEMIDE THERAPEUTIC DRUG MONITORING IN NEONATES ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
    van der Vorst, M.
    van Heijst, A.
    den Hartigh, J.
    Burggraaf, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 130 - 131
  • [30] Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates
    Tian Yu
    Alfred H. Balch
    Robert M. Ward
    E. Kent Korgenski
    Catherine M. T. Sherwin
    BMC Pharmacology and Toxicology, 17
12345